Endovia Health Sciences vs Innovation Beverage
EDVA and IBG side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EDVA | IBG |
|---|---|---|
| Size and price | ||
| Market cap | $130K | – |
| Share price | $0.173 | $0.760 |
| Change, 1 year | −96.2% | −92.7% |
| Change, 5 years | −99.9% | – |
| Beta (5Y) | 1.03 | −0.17 |
| Employees | 1 | 8 |
| StockData Score | ||
| Total score | 0 | 0 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 0 | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | – | −5.1% |
| Revenue growth, 5Y average | −49.8% | – |
| Profitability | ||
| Gross margin | – | 44.2% |
| Operating margin | – | −194% |
| Net margin | – | −223% |
| FCF margin | – | −56.7% |
| Financial health | ||
| Interest coverage | −5.7× (better) | −45.8× |
| Current ratio | 0.05 | 0.27 (better) |
| Altman Z-score | −302.17 | – |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 37.0% | 11.2% |
| Held by insiders | – | 3.5% |
| Short interest, % of float | – | 7.1% |
Go deeper
- EDVA stock overview
- EDVA income statement
- EDVA valuation and score
- IBG stock overview
- IBG income statement
- IBG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.